BridgeMD
New treatment option for Frozen Shoulder
Official title USG-Guided Shoulder Injections in Frozen Shoulder
ClinicalTrials.gov ID: NCT07493213
What this study is testing
- What it's testing
- Frozen shoulder (adhesive capsulitis) is characterized by pain and a progressive restriction of both active and passive shoulder range of motion, significantly impairing daily activities and quality of life. This study aims to evaluate the effectiveness of USG-guided shoulder injections, when added to a home-based exercise program, in the conservative management of patients with chronic, painful frozen shoulder.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age between 18 and 75 years and willingness to participate in the study
- Presence of shoulder pain lasting at least 3 months and a diagnosis of primary frozen shoulder
- Pain intensity ≥ 4/10 on the Visual Analog Scale (VAS), resistant to medical treatment/analgesics
- Restriction of ≥30 degrees in at least two planes of shoulder motion (flexion, abduction, or external rotation)
You likely can't join if
- History of shoulder trauma
- Presence of neurological conditions such as stroke, brachial plexus injury, Parkinson's disease, or cervical spine pathology with or without...
- History of shoulder surgery, shoulder malignancy or tumor, or prior shoulder manipulation
- Presence of shoulder arthritis, rotator cuff tear, other shoulder injuries, or thoracic outlet syndrome
- Systemic diseases affecting the shoulder, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, labral or articular cartilage...
- Steroid injection to the affected extremity within the last 3 months, use of oral steroids or NSAIDs, or ongoing surgical/treatment treatment
See the full eligibility criteria
- Age between 18 and 75 years and willingness to participate in the study
- Presence of shoulder pain lasting at least 3 months and a diagnosis of primary frozen shoulder
- Pain intensity ≥ 4/10 on the Visual Analog Scale (VAS), resistant to medical treatment/analgesics
- Restriction of ≥30 degrees in at least two planes of shoulder motion (flexion, abduction, or external rotation)
- History of shoulder trauma
- Presence of neurological conditions such as stroke, brachial plexus injury, Parkinson's disease, or cervical spine pathology with or without radiculopathy
- History of shoulder surgery, shoulder malignancy or tumor, or prior shoulder manipulation
- Presence of shoulder arthritis, rotator cuff tear, other shoulder injuries, or thoracic outlet syndrome
- Systemic diseases affecting the shoulder, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, labral or articular cartilage injuries), or inflammatory rheumatic diseases
- Steroid injection to the affected extremity within the last 3 months, use of oral steroids or NSAIDs, or ongoing surgical/treatment treatment
- Pregnancy or lactation
- Uncontrolled diabetes, heart failure, or uncontrolled systemic diseases (e.g., liver failure, chronic kidney disease, significant endocrine disorders)
- Communication problems or severe psychiatric disorders
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Selçuklu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Selçuklu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.